Immune and cytological features of restoration of the nasal mucosa after combined treatment of chronic rhinosinusitis
- 11 September 2026
- journal article
- Published by Media Sphere Publishing Group in Russian Rhinology
- Vol. 34 (3)
Abstract
Objective. To determine immunological, cytological and microbiome markers of the formation of functional deficit of the nasal mucosa (NM) after combined treatment of chronic rhinosinusitis (CRS). Patients and methods. A study of nasopharyngeal lavage cytokines (interleukin-1, -4, -6 and tumor necrosis factor-α), results of brush microbiopsy of the NM by an original method and analysis of DNA markers of opportunistic microorganisms and resident viruses were carried out in 108 patients with various nosological forms of CRS who underwent surgery or outpatient treatment with medium-dose intranasal glucocorticosteroids. The studies were performed upon admission and discharge from the hospital as well as 1 month after discharge. Results. Regression analysis identified predictors and protectors of functional deficit of the NM after combined treatment of CRS, which developed in 26% of patients. The following indicators were predictors of this functional deficit: high concentrations of interleukin-6 and interferon-α in nasopharyngeal lavage before surgery, as well as increased expression of DNA markers of the Staphylococcaceae family according to polymerase chain reaction data and coccal microflora according to brush microbiopsy of the NM. From anamnestic data, the patient’s smoking and exacerbations of CRS after acute respiratory viral infections were the predictors of this functional deficit. Conclusion. An effective and significant logistic equation that can be used to assess the risk of developing functional deficit of the NM after combined treatment of CRS was obtained.Keywords
This publication has 13 references indexed in Scilit:
- Efficacy of Clarithromycin Combined with Fluticasone Propionate on Nasal Function, Nasal Mucociliary Transport Function, and Serum Inflammatory Markers in Chronic Rhinosinusitis Patients After Functional Endoscopic Sinus SurgeryEar, Nose & Throat Journal, 2024
- Features of inflammatory endotypes and phenotypes in chronic rhinosinusitisRussian Bulletin of Otorhinolaryngology, 2024
- Pathogenesis and treatment of chronic rhinosinusitis from the perspective of sinonasal epithelial dysfunctionFrontiers in Medicine, 2023
- Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factorsJournal of Allergy and Clinical Immunology, 2022
- Mucus composition abnormalities in sinonasal mucosa of chronic rhinosinusitis with and without nasal polypsInflammation, 2021
- Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitisAnnals of Allergy, Asthma & Immunology, 2020
- European Position Paper on Rhinosinusitis and Nasal Polyps 2020Rhinology journal, 2020
- EPOS-2020. What’s new?Russian Rhinology, 2020
- Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatologyJournal of Allergy and Clinical Immunology, 2019
- Evaluation of nasal mucociliary clearance after medical or surgical treatment of chronic rhinosinusitis2009